$RPD

Rapid7 to Report Second Quarter 2026 Financial Results on August 10

Rapid7, Inc. (NASDAQ: RPD) said it will release its Q2 2026 financial results on Aug. 10, 2026, after market close, and hold an earnings call the same day at 4:30 p.m. ET to discuss results and outlook. The webcast and press release will be posted on its investor relations site.

Original reporting
Published Jul 14, 2026, 11:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 12:17 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$RPD
Neutral
medium confidence
Mentioned
$RPD
Relevance
4/10
alphai data visualization · based on itnewsonline.com
Decision brief

The 30-second read

$RPDNeutralMed
01

Why it matters

The main tradable element is the event timing, which can affect implied volatility and hedging demand before the print.

02

Market read

This sets the earnings event window for RPD, but provides no new numbers or guidance in the text.

03

What to watch

Traders should focus on what management typically emphasizes in MDR demand, margins, and guidance, since this PR provides no qualitative outlook.

Relevance 4/10Novelty 4/10Timing: Ahead of Rapid7’s Q2 2026 earnings release on Aug 10 after the close.

Background

Rapid7 is a managed cybersecurity operations provider, and the company is scheduling its Q2 2026 earnings release and call.

Company-level read

Ticker impact

$RPDNeutralMedium confidence
Context

Rapid7 announced it will release Q2 2026 results on Aug 10 after the close, with a conference call at 4:30 p.m. ET.

Expected impact

Likely elevated options and share volatility into Aug 10; direction depends on the eventual print and outlook.

Evidence & confidence

The article discloses only the timing of results and the call, not any new financial figures or guidance.

Market effects

Could drive short-term sentiment and trading activity across managed cybersecurity/MDR peers around the same earnings season window.

Primarily US-listed tech/cybersecurity sentiment into the earnings date.

Limited global read-through since no guidance, contract, or regulatory development is disclosed.

Counterpoint

Because the release date is already knowable from typical investor calendars, the incremental trading edge may be small unless positioning is already crowded.

Key entities

  • Rapid7, Inc.

    NASDAQ-listed cybersecurity company releasing Q2 2026 results on Aug 10 and holding a call at 4:30 p.m. ET.

  • Conference call

    Scheduled for Aug 10, 2026 at 4:30 p.m. Eastern Time to discuss results and business outlook.

Related articles

$OFIXMed

These 7 Small Caps Are On Fire In July: Here's Why - ExxonMobil Holdings (NYSE:XOM), Vertex Pharmaceutica

The Russell 2000 stayed near 3,000 with little movement, while seven small-cap stocks gained at least 28% in four sessions. The article cites July surges for Orthofix (OFIX) on CMS reimbursement reversal, REGENXBIO (RGNX) on FDA resubmission alignment and AbbVie milestone, Verastem (VSTM) on short-squeeze setup, ADC Therapeutics (ADCT) rebound, Sable Offshore (SOC) refinancing, Rapid7 (RPD) takeover speculation, and Crinetics (CRNX) surge toward an offer price.

$RPDMedAI 8/10

Rapid7 (RPD) Stock Trades Down, Here Is Why

Rapid7 (NASDAQ: RPD) shares fell 11.3% in the morning after Morgan Stanley downgraded the stock from Equal Weight to Underweight and kept a $9 price target. The firm cited competitive pressure in vulnerability management from AI-focused rivals and said Rapid7 has lagged in exposure management and real-time remediation. RPD is down 26.5% YTD.

$RPDMedAI 8/10

Rapid7 (RPD) Releases Findings of Q1 Threat Landscape Report

Rapid7 (NASDAQ:RPD) released its Q1 2026 Threat Landscape Report on May 21, citing vulnerability exploitation as 38% of incident response cases. The company said AI is speeding attackers’ ability to identify and exploit unpatched systems. Separately, Barclays lowered its price target and kept an Underweight rating after Rapid7’s Q1 results, citing weaker-than-expected Q2 ARR guidance. Rapid7 projects Q2 ARR of about $820M versus $832M in Q1.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).